课题基金 / 基金详情

Regulation of Apoptosis by Integrin

Regulation of Apoptosis by Integrin
整合素对细胞凋亡的调节
批准号:
6989472
负责人:
ERKKI RUOSLAHTI
金额:
$20.5万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-09-22 至 2009-08-31

项目摘要

项目成果

ERKKI RUOSLAHTI的其他基金

相似基金

相关文献

中文摘要
翻译
整合素介导的细胞粘附至细胞外基质(ECM)的最重要的细胞功能之一是通过介导从ECM至细胞的抗凋亡信号来促进细胞存活。大多数类型的细胞依赖于ECM附着生存;如果拒绝它,它们会发生凋亡(失巢凋亡)。恶性细胞比正常细胞更少依赖于整合素介导的存活信号。由一些但不是全部整合素激活的途径上调抗凋亡蛋白Bcl-2。在筛选调节该途径的cDNA时,我们分离了一种新蛋白质的eDNA,我们将其命名为Bit 1。Bit 1是一种线粒体蛋白,当释放到细胞质中时,会诱导细胞凋亡。酵母双杂交筛选和生化数据 揭示了Bit 1和转录调节蛋白氨基末端分裂增强子(AES)之间的相互作用。AES的强制表达也引起细胞凋亡。细胞凋亡的程度与细胞质中Bit 1-AES复合物的水平相关,表明该复合物是促凋亡因子。Bcl-2、Bcl-xL、各种半胱天冬酶抑制剂或活化的PI 3-K、Akt或H-Ras转染不阻断AES或胞质Bit 1诱导的凋亡。将细胞接种到纤连蛋白上是迄今为止唯一确定的抵消Bit 1和AES诱导骨坏死作用的治疗方法。使用替代粘合表面 抗体抑制实验表明,Bit 1/AES的抗凋亡作用受特异性整合素的调控。Bit 1/AES通路可能至少部分地负责整合素介导的细胞粘附的抗凋亡作用。本申请提出了建立Bit 1/AES途径的整合素调节并鉴定调节它的整合素的子集的实验。整合素调节研究将集中于Bit 1/AES复合物(假定的促凋亡因子)的形成。并对配合物进行了晶体学研究。最后,我们将分析在正常情况下Bit 1的体内功能, 生理学和肿瘤发生的条件Bit 1基因敲除,这是已经在手。这些研究的结果可能描绘了一个信号通路,是在正常细胞的锚定依赖性的根本重要性。变成恶性的细胞可以绕过该途径而变得不依赖于锚定和转移。
英文摘要
One of the most important cellular functions of integrin-mediated cell adhesion to extracellular matrix (ECM) is to promote cell survival by mediating anti-apoptotic signals from ECM to cells. Most types of cells depend on ECM attachment for survival; if denied it, they undergo apoptosis (anoikis). Malignant cells are less dependent on integrin-mediated survival signals than normal cells. A pathway activated by some, but not all, integrins up-regulates the anti-apoptotic protein Bcl-2. In screening for cDNAs that regulate this pathway, we isolated a eDNA for a novel protein, which we have named Bit1. Bit1 is a mitochondrial protein which, when released into the cytoplasm, induces apoptosis. Yeast two-hybrid screening and biochemical data revealed an interaction between Bit1 and the transcriptional regulator protein Amino-terminal Enhancer of Split (AES). Forced expression of AES also causes apoptosis. The degree of apoptosis correlates with the level of Bit1-AES complexes in the cytoplasm, suggesting that the complex is the pro-apoptotic factor. Transfection with Bcl-2, Bcl-xL, various caspase inhibitors, or activated PI3-K, Akt or H-Ras, does not block apoptosis induced by AES or cytoplasmic Bit1. Plating cells onto fibronectin is the only treatment identified so far that counteracts the apoptosis-inducing effect of Bit1 and AES. The use of alternative adhesion surfaces and antibody inhibition experiments suggests that the anti-apoptotic effect of Bit1/AES is regulated by specific integrins. The Bit1/AES pathway may be, at least in part, responsible for the anti-apoptotic effect of integrin-mediated cell adhesion. This application proposes experiments to establish the integrin-regulation of the Bit1/AES pathway and to identify the subset of integrins that regulate it, The integrin regulation studies will focus on the formation of the Bit1/AES complex, the presumed pro-apoptotic factor. A crystallographic study on the complex is also proposed. Finally, we will analyze the in vivo function of Bit1 in normal physiology and in tumorigenesis by using a conditional Bit1 gene knockout, which is already at hand. The results of these studies may delineate a signaling pathway that is of fundamental importance in the anchorage dependence of normal cells. Cells that become malignant may bypass this pathway in becoming anchorage independent and metastatic.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
New Molecular Signatures in Alzheimer's Disease
A nanosystem for tumor treatment and imaging
A nanosystem for tumor treatment and imaging
High-throughput screen to identify modulators of CendR-mediated cellular uptake
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
  • 批准号:
    31970691
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2019
  • 负责人:
    张胜萍
  • 依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
  • 批准号:
    31900527
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2019
  • 负责人:
    孙磊
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位: